These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33624419)

  • 1. Targeting tumour necrosis factor to ameliorate viral pneumonia.
    Pandey P; Karupiah G
    FEBS J; 2022 Feb; 289(4):883-900. PubMed ID: 33624419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Targeting of Inflammation and Virus Simultaneously Ameliorates Influenza Pneumonia and Protects from Morbidity and Mortality.
    Pandey P; Al Rumaih Z; Kels MJT; Ng E; Kc R; Malley R; Chaudhri G; Karupiah G
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting ectromelia virus and TNF/NF-κB or STAT3 signaling for effective treatment of viral pneumonia.
    Pandey P; Al Rumaih Z; Kels MJT; Ng E; Kc R; Chaudhri G; Karupiah G
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poxvirus-encoded TNF receptor homolog dampens inflammation and protects from uncontrolled lung pathology during respiratory infection.
    Al Rumaih Z; Tuazon Kels MJ; Ng E; Pandey P; Pontejo SM; Alejo A; Alcamí A; Chaudhri G; Karupiah G
    Proc Natl Acad Sci U S A; 2020 Oct; 117(43):26885-26894. PubMed ID: 33046647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF deficiency dysregulates inflammatory cytokine production, leading to lung pathology and death during respiratory poxvirus infection.
    Tuazon Kels MJ; Ng E; Al Rumaih Z; Pandey P; Ruuls SR; Korner H; Newsome TP; Chaudhri G; Karupiah G
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15935-15946. PubMed ID: 32571912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice.
    Shi X; Zhou W; Huang H; Zhu H; Zhou P; Zhu H; Ju D
    Crit Care; 2013 Dec; 17(6):R301. PubMed ID: 24373231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase-1 (HO-1) cytoprotective pathway: A potential treatment strategy against coronavirus disease 2019 (COVID-19)-induced cytokine storm syndrome.
    Rossi M; Piagnerelli M; Van Meerhaeghe A; Zouaoui Boudjeltia K
    Med Hypotheses; 2020 Nov; 144():110242. PubMed ID: 33254548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of lung inflammation and immunopathology by TNF-α during acute influenza infection.
    Damjanovic D; Divangahi M; Kugathasan K; Small CL; Zganiacz A; Brown EG; Hogaboam CM; Gauldie J; Xing Z
    Am J Pathol; 2011 Dec; 179(6):2963-76. PubMed ID: 22001698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management.
    Mohd Zawawi Z; Kalyanasundram J; Mohd Zain R; Thayan R; Basri DF; Yap WB
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.
    Traboulsi H; Cloutier A; Boyapelly K; Bonin MA; Marsault É; Cantin AM; Richter MV
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6317-27. PubMed ID: 26248373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygalasaponin F treats mice with pneumonia induced by influenza virus.
    Ye Y; Wang H; Liu J; Zhao F; Xu P
    Inflammopharmacology; 2020 Feb; 28(1):299-310. PubMed ID: 31446589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-705 (Favipiravir) suppresses tumor necrosis factor α production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug.
    Tanaka T; Kamiyama T; Daikoku T; Takahashi K; Nomura N; Kurokawa M; Shiraki K
    Acta Virol; 2017; 61(1):48-55. PubMed ID: 28105854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting.
    Amere Subbarao S
    Inflammopharmacology; 2021 Apr; 29(2):343-366. PubMed ID: 33723711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.